Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine
Nanomedicine is ongoing current research in the applications of nanotechnology for cancer therapy. Simply from a technology perspective, this field of research has an enormous broadening and success to date. Recently, nanomedicine has also made inroads in the treatment of cancer. Stimuli-responsive...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
De Gruyter
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6bdfd982d90d4b4dabebe5ae4b661795 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6bdfd982d90d4b4dabebe5ae4b661795 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6bdfd982d90d4b4dabebe5ae4b6617952021-12-05T14:10:58ZSmart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine2191-909710.1515/ntrev-2021-0067https://doaj.org/article/6bdfd982d90d4b4dabebe5ae4b6617952021-08-01T00:00:00Zhttps://doi.org/10.1515/ntrev-2021-0067https://doaj.org/toc/2191-9097Nanomedicine is ongoing current research in the applications of nanotechnology for cancer therapy. Simply from a technology perspective, this field of research has an enormous broadening and success to date. Recently, nanomedicine has also made inroads in the treatment of cancer. Stimuli-responsive nanoparticles are an emerging field of research because its targeting capacity is of great interest in the treatment of cancer. The responsive nanoparticles are efficient in encountering different internal biological stimuli (acidic, pH, redox, and enzyme) and external stimuli (temperature, ultrasounds, magnetic field, and light), which are used as smart nanocarriers for delivery of the chemotherapeutic and imaging agents for cancer therapy. In-depth, the responsive nanocarrier that responds to the biological cues is of pronounced interest due to its capability to provide a controlled release profile at the tumor-specific site. The outlook of this review focuses on the stimuli-responsive nanocarrier drug delivery systems in sequence to address the biological challenges that need to be evaluated to overcome conventional cancer therapy.Murugan BaranyaSagadevan SureshFatimah IsOh Won-ChunMotalib Hossain Mohd AbdJohan Mohd RafieDe Gruyterarticlenanocarrierstimuli-responsivedrug deliverygene therapytargeted therapyphotodynamic therapyTechnologyTChemical technologyTP1-1185Physical and theoretical chemistryQD450-801ENNanotechnology Reviews, Vol 10, Iss 1, Pp 933-953 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
nanocarrier stimuli-responsive drug delivery gene therapy targeted therapy photodynamic therapy Technology T Chemical technology TP1-1185 Physical and theoretical chemistry QD450-801 |
| spellingShingle |
nanocarrier stimuli-responsive drug delivery gene therapy targeted therapy photodynamic therapy Technology T Chemical technology TP1-1185 Physical and theoretical chemistry QD450-801 Murugan Baranya Sagadevan Suresh Fatimah Is Oh Won-Chun Motalib Hossain Mohd Abd Johan Mohd Rafie Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine |
| description |
Nanomedicine is ongoing current research in the applications of nanotechnology for cancer therapy. Simply from a technology perspective, this field of research has an enormous broadening and success to date. Recently, nanomedicine has also made inroads in the treatment of cancer. Stimuli-responsive nanoparticles are an emerging field of research because its targeting capacity is of great interest in the treatment of cancer. The responsive nanoparticles are efficient in encountering different internal biological stimuli (acidic, pH, redox, and enzyme) and external stimuli (temperature, ultrasounds, magnetic field, and light), which are used as smart nanocarriers for delivery of the chemotherapeutic and imaging agents for cancer therapy. In-depth, the responsive nanocarrier that responds to the biological cues is of pronounced interest due to its capability to provide a controlled release profile at the tumor-specific site. The outlook of this review focuses on the stimuli-responsive nanocarrier drug delivery systems in sequence to address the biological challenges that need to be evaluated to overcome conventional cancer therapy. |
| format |
article |
| author |
Murugan Baranya Sagadevan Suresh Fatimah Is Oh Won-Chun Motalib Hossain Mohd Abd Johan Mohd Rafie |
| author_facet |
Murugan Baranya Sagadevan Suresh Fatimah Is Oh Won-Chun Motalib Hossain Mohd Abd Johan Mohd Rafie |
| author_sort |
Murugan Baranya |
| title |
Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine |
| title_short |
Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine |
| title_full |
Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine |
| title_fullStr |
Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine |
| title_full_unstemmed |
Smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine |
| title_sort |
smart stimuli-responsive nanocarriers for the cancer therapy – nanomedicine |
| publisher |
De Gruyter |
| publishDate |
2021 |
| url |
https://doaj.org/article/6bdfd982d90d4b4dabebe5ae4b661795 |
| work_keys_str_mv |
AT muruganbaranya smartstimuliresponsivenanocarriersforthecancertherapynanomedicine AT sagadevansuresh smartstimuliresponsivenanocarriersforthecancertherapynanomedicine AT fatimahis smartstimuliresponsivenanocarriersforthecancertherapynanomedicine AT ohwonchun smartstimuliresponsivenanocarriersforthecancertherapynanomedicine AT motalibhossainmohdabd smartstimuliresponsivenanocarriersforthecancertherapynanomedicine AT johanmohdrafie smartstimuliresponsivenanocarriersforthecancertherapynanomedicine |
| _version_ |
1718371541873328128 |